1. Homogenates of rat liver, spleen, heart and kidney form lipid peroxides when incubated in vitro and actively catalyse peroxide formation in emulsions of linoleic acid or linolenic acid. 2. In liver, catalytic activity is distributed throughout the nuclear, mitochondrial and microsomal fractions and is present in the 100OOOg supernatant. Activity is weak in the nuclear fraction. 3. Dilute (0.5%, w/v) homogenates catalyse peroxidation over the range pH5-0-8-0 but concentrated (5%, w/v) homogenates inhibit peroxidation and destroy peroxide if the solution is more alkaline than pH 7*0. 4. Ascorbic acid increases the rate of peroxidation of unsaturated fatty acids catalysed by whole homogenates of liver, heart, kidney and spleen at pH 60 but not at pH 7-4. 5. Catalysis of peroxidation of unsaturated fatty acids by the mitochondrial and microsomal fractions of liver is inhibited by ascorbic acid at pH 7 4 but the activity of the supernatant fraction is enhanced. 6. Inorganic iron or ferritin are active catalysts in the presence of ascorbic acid. 7. Lipid peroxide formation in linoleic acid or linolenic acid emulsions catalysed by tissue homogenates is partially inhibited by EDTA but stimulated by o-phenanthroline. 8. Cysteine or glutathione (lmM) inhibits peroxide formation catalysed by whole homogenates, mitochondria or haemoprotein. Inhibition increases with increase of pH.
Linoleic acid peroxide and peroxides of other unsaturated fatty acids are extremely toxic when injected into mice (Horgan, Philpot, Porter & Roodyn, 1957) . This toxicity may be a result of oxidative destruction of thiol groups of amino acids and proteins (Lewis & Wills, 1962) and particularly of enzymes (Wils, 1961) . Lipid peroxide formation may also result in membrane damage, as has been shown for erythrocytes (Tsen & Collier, 1960) and lysosomes (Wills & Wilkinson, 1966) . Formation of lipid peroxides in vivo would therefore be very likely to cause severe cellular damage. Under certain conditions, lipid peroxides may be formed in vivo but accurate analysis is difficult and reported results are controversial (Zalkin & Tappel, 1960; Bieri & Anderson, 1960; Philpot, 1963) . Nevertheless it is firmly established that homogenates of most animal tissues form thiobarbituric acid reactants (commonly called 'peroxides') when incubated in vitro under aerobic conditions (Zalkin & Tappel, 1960) . These substances are believed to be formed by the oxidation of unsaturated fatty acids of lipid constituents of the tissues probably via hydroperoxides (Holman, 1954) . Such studies in vitro are clearly useful for the formulation of possible mechanisms of peroxide formation in vivo.
Two separate systems have been implicated in the catalysis of lipid peroxide formation in tissues: haemoproteins such as haemoglobin or cytochrome c are well established as active catalysts in vitro (Tappel, 1955) , but iron in the non-haem form has frequently been considered to be more important as a catalyst in tissues (Bernheim, 1963) . Peroxide formation in tissues is stimulated by ascorbic acid (Wolfson, Wilbur & Bernheim, 1956) and is inhibited by EDTA (Barber, 1963) .
The value of studies on lipid peroxide formation in incubated tissue homogenates is limited by two main considerations. First, lipid peroxide formation in tissues clearly requires substrates, the unsaturated fatty acids of the tissue lipids, and a catalytic system. Either of these factors may limit or control the extent of peroxide formation. Secondly, nearly all investigations have, so far, relied on the thiobarbituric acid colorimetric method for peroxide determination. This method does not measure lipid peroxide directly but actually measures the concentration of malonaldehyde or other degradation products such as 2,4-dienals or 2-enals, which are split from peroxidized unsaturated fats. During the initial stages of peroxidation of pure unsaturated fatty acids such as linolenic acid this 'thiobarbituric acid value' is directly proportional to the peroxide value (Wills & Rotblat, 1964) but the thiobarbituric acid method may be unreliable under certain conditions (Philpot, 1963; Wills, 1964a) .
To overcome some of these difficulties the 667 E. D. WILLS catalytic systems of tissues have been studied by the addition of excess of substrate in the form of emulsions of unsaturated fatty acids to tissue homogenates. This procedure enables other methods of studying oxidation and peroxide formation, such as the measurement of oxygen uptake, to be used and to be compared with the thiobarbituric acid method. Attempts have been made to assess the relative importance of haemoprotein catalysis and inorganic (non-haem) iron catalysis in various tissues by comparing results with those found for these catalysts in model systems (Wills, 1965) .
Rates of peroxide formation catalysed by various tissues have been compared and effects of varying the experimental conditions and of adding chelating agents examined. A preliminary account of this work has been published (Wills, 1964b) . EXPERIMENTAL Linoleic acid and linolenic acid emulsions. These were prepared as previously described (Wills, 1965) .
Buffer solutions. These were prepared as described by Dawson, Elliott, Elliott & Jones (1959) . Tris-HCl or phosphate buffers were used in most experiments.
Ferritin. This was prepared from pig spleen as described by Michaelis (1947 Oxidation studies. The rates of peroxidation of emulsions oflinoleic acid or linolenic acid were studied manometrically as described previously (Wills, 1965) . In a typical experiment 2-0ml. of fatty acid emulsion (0-02M) in phosphate or tris-HCl buffer was mixed with 0-3ml. of tissue homogenate (10%, w/v) and the rate of 02 uptake determined at 370 for 60min. in a total volume of 3ml. When linolenic acid oxidation was studied samples (0-2 ml.) were taken immediately after mixing homogenates and emulsion and then again after 60min. incubation for determination of the lipid 'peroxide' concentration by the thiobarbituric acid method (Wilbur, Bernheim & Shapiro, 1949) . This colorimetric method is not suitable for the study of linoleic acid peroxidation (Wilbur et al. 1949) .
The original method of Wilbur et al. (1949) utilized 2-0ml. of sample with 10ml. of 20% (w/v) trichloroacetic acid and 2-0ml. of 0-67% (w/v) thiobarbituric acid. In the present investigation it was usually desirable to decrease the sample size to 0-2ml. or 0-5ml. and make the reaction volume up to 5-0 ml. Although it is possible, when studying peroxidation of pure linolenic acid, to convert E535 values into molar concentrations of peroxide (Wills & Rotblat, 1964) (Wagner, Clever & Peters, 1947) or by measuring E232 (Holman, 1954) . For the latter measurements the emulsions were clarified by diluting with a suitable volume of 0-01 N-NaOH in 10% (vfv) ethanol.
Iron content. Iron contents of tissues were determined on tissue homogenates by the method described by Ramsay (1951 Ramsay ( , 1954 Linolenic acid emulsion (16-7 mM) in 0*02M-phosphate buffer, pH6-0, was incubated at 370 for 60min. with the tissue homogenate in a total volume of 3ml. Samples (0.2ml.) were removed for the determinations of the thiobarbituric acid (TBA) value (as E535) immediately after adding the homogenate and then again after 60mw.
incubation. o, Heart; A, spleen; *, liver;o, kidney. barbituric acid value of 1 corresponds closely to a peroxide concentration of 1-4,moles/ml. in oxidized linolenic acid when peroxide concentration is determined by measuring E232. The discrepancy between the two values was more marked when ascorbic acid was present.
Effect of pH. At pH 6-0, the rate of peroxidation of fatty acid emulsions catalysed by liver homogenate increased with homogenate concentration until the final homogenate concentration was 4% E. D. WILLS of the dilute (0.5%, w/v) kidney homogenate was at least six times that of the concentrated (5%, w/v) homogenate (Fig. 3) . Essentially similar results were obtained with homogenates of heart or spleen.
Effect of ascorbic acid. Tissue homogenates incubated in the presence of ascorbic acid form much more lipid 'peroxide', as measured by the thiobarbituric acid method, than when no ascorbic acid is added (Wolfson et al. 1956 ). Further, tissues Conen. of homogenate (%, w/v) Fig. 2 . Relation between concentration of liver homogenate and the rate of linoleic acid peroxidation at pH6-0 and pH7.4. Linoleic acid emulsion (16-7mm) in 0-02M-phosphate buffer, pH6-0 or 7-4, was incubated at 370 for 60min. with liver homogenate in a total volume of 3ml. 02 uptake was followed manometrically. *, pH6-0; A, pH 7-4. from ascorbic acid-deficient guinea pigs form less 'peroxide' after incubation than normal tissues do (Abramson, 1949) . Ascorbic acid had little effect on the rate of peroxidation of linolenic acid catalysed by spleen homogenates, but when added to liver, kidney or heart homogenate (1%, w/v) in phosphate buffer, pH 6-0, it caused marked increases in the rate of peroxidation of the linolenic acid and in the thiobarbituric acid values (Table 3) . Although ascorbic acid increased the rate of peroxidation of unsaturated fatty acids in solutions more acid than pH 6-0 it inhibited the initial rate (Ramsay, 1951) haemoproteins are destroyed. Any catalytic function of haemoproteins should therefore be completely destroyed by prior treatment with hydrogen peroxide. The liberated inorganic iron is a very weak catalyst as compared with an equivalent quantity of haem iron (Wills, 1965) .
Treatment of homogenates of heart, spleen, liver and kidney with hydrogen peroxide for 5min. at 500 decreased the catalytic activity for peroxidation of linoleic acid to a small percentage of the original activity. Addition of ascorbic acid to the treated homogenates caused a rapid rate of peroxidation (Table 4) owing to the formation of an active catalytic system with the non-haem iron.
Effect of chelating agent8. The rate of ironcatalysed peroxidation of linoleic acid emulsions is strongly stimulated by o-phenanthroline but strongly inhibited by EDTA; the haemoproteincatalysed oxidation is, on the other hand, unaffected by chelating agents (Wills, 1965) . Addition of chelating agents to tissue homogenates should therefore help to elucidate the nature of the catalytic system in the tissue.
EDTA (0-2mm) strongly inhibited linolenic acid peroxidation catalysed by kidney and liver homogenates and weakly inhibited the peroxidation catalysed by heart and spleen homogenates (Table 5 ). Increases in the rate of 'peroxide' formation caused by the addition of ascorbic acid were, however, almost completely abolished by EDTA (Table 5) . Therefore a heavy metal, which is likely to be non-haem iron, must play a vital role in such reactions.
Endogenous lipid 'peroxide' formation, measured by the thiobarbituric acid method, in tissue homogenates (1%) incubated in the presence of ascorbic acid (1mM) was also strongly inhibited by EDTA (0 2mm), inhibition being virtually complete in spleen and kidney homogenates and about 60% in heart and liver homogenates.
o-Phenanthroline or 8-hydroxyquinoline form complexes with inorganic iron that are very effective as catalysts of the peroxidation of unsaturated fatty acids (Wills, 1965) . If non-haem iron is an important catalytic constituent of tissues it would therefore be expected that the addition of o-phenanthroline to tissue homogenates would accelerate the rate of peroxide formation. Addition of o-phenanthroline (1 mM) did enhance the rate of peroxidation of linolenic acid emulsions catalysed by heart, spleen, kidney or liver homogenates but it strongly inhibited endogenous peroxide formation in incubated homogenates (Table 6 ). Similar effects were obtained with 8-hydroxyquinoline.
Effect of added haemoglobin. Haemoglobin and other haemoproteins are very active catalysts of lipid peroxide formation in solutions more dilute than 10uM but inhibit peroxide formation in more concentrated solutions (Lewis & Wills, 1963) . Addition of haemoglobin to kidney homogenates increased endogenous lipid 'peroxide' formation if its concentration was not more than 10uM but completely inhibited 'peroxide' formation at concentrations above 50mM (Fig. 4) . Results with liver and heart homogenates were essentially similar. relation to the weight of liver used for the preparation.
Iron content of tis8ues. All tissues contained both non-haem and haem iron ( Table 7) .
The very high concentration of haem iron in spleen is no doubt responsible for most of the catalytic activity observed with this tissue, whereas kidney catalysis probably depends considerably on non-haem iron. The high concentration of nonhaem iron in spleen is mainly iron that is combined as ferritin or haemosiderin and is inactive catalytically. It is noteworthy that spleen-catalysed peroxidation is little stimulated by ascorbic acid whereas peroxidation catalysed by kidney homogenate is powerfully stimulated (Table 3) . Catalysis of peroxidation of unsaturated fatty acids by liver fractions. Little catalytic activity was associated with the nuclear fraction when the blood had been completely removed but the mitochondria, microsomes and final supernatant all possessed activity (Table 8) . Ascorbic acid (1mM) decreased 'peroxide' formation in the nuclear, mitochondrial and microsomal fractions to about 30% of the control at pH7-4 but the catalytic activity of the supernatant fraction was increased by ascorbic acid (Table 8) . o-Phenanthroline (1 mm) increased the catalytic activity of all fractions for the peroxidation of linoleic acid, whole liver 3-26-fold, mitochondria 3*47-fold and microsomes 2-32-fold, but the increase was especially marked in the supernatant fraction, which was 8-36 times as active as the control with no o-phenanthroline. The importance of cytochrome c in mitochondrial catalysis was established by decreasing the concentration of cytochrome c by the method of Jacobs & Sanadi (1960) . This treatment decreased the rate of peroxidation of linoleic acid emulsion to 35% of that catalysed by normal mitochondria. GSH at a concentration of 2mM inhibited mitochondrial catalysis of the peroxidation of linoleic acid and linolenic acid. However, with 5mM-GSH a rapid rate of peroxidation ensued, as measured both by oxygen uptake and by the thiobarbituric acid method (Fig. 6) . Peroxidation catalysed by 10,um-cytochrome c was inhibited by 1 mM-GSH, and increasing the concentration of GSH caused increased inhibition (Fig. 6) . Bioch. 1966, 99 Vol. 99 673
In 1. r result. Leakage of lysosomal enzymes has been associated with lipid peroxide formation in lysosomes (Wills & Wilkinson, 1966) . Secondly, peroxides may have toxic effects on vital cell constituents. For example, lipid peroxides can inactivate thiol enzymes (Wills, 1961) and oxidize thiol groups of amino acids, peptides and proteins (Lewis & Wills, 1962) . In addition, it is possible that hydroperoxide formation could constitute an important metabolic pathway; thus it has been proposed that the hydroperoxide of cholesterol linoleate is responsible for the introduction of a hydroxyl group into the sterol ring (Boyd, 1962) .
The present experiments demonstrate that the tissues studied, liver, kidney, spleen and heart, can ut when ascorbic an oxygen uptake of about 0.89 mole/ml. As ixidation ensued. described in the Results section, this quantity is was most rapid less than the concentration of 'peroxide' that was known to release determined by the thiobarbituric acid method, Shorr, 1955) and namely 1 4,umoles of peroxide/ml. There are two iron is an active possible explanations for this. First, there are ity (Wills, 1965) . difficulties in the determination of the molar extinction coefficient of peroxide at 232m,u (Mead, 1952) , and, secondly, it is likely that partially oxidized fatty acids in tissue homogenates could n vivo is difficult break down without further oxygen uptake to give a question as to fragments that are determined by the thio-)d in vivo is not barbituric acid method. Experiments with ascorbic ad tissue always acid (Table 3) Ferritin and fatty acid oxidation. tion of tissue non-haem iron is stc of ferritin and haemosiderin. This: in liver and spleen. Ferritin (0 increase the rate of peroxidation emulsion in the range pH 4 0-7 4 bi acid was added a rapid rate of pero The rate was pH-dependent, and at pH 6.0 (Fig. 7) . Ascorbic acid is iron from ferritin (Mazur, Baez & I it has been shown that inorganic i catalyst on the acid side of neutrali DISCUSSION Reliable analysis of peroxides it (Philpot, 1963) , and therefore th( whether lipid peroxides are forme yet resolved. Nevertheless isolatE contains some 'peroxide' (Zalkin Bieri & Anderson, 1960 There was poor agreement between increase of oxygen uptake and thiobarbituric acid values produced by the addition of ascorbic acid, the increase of thiobarbituric acid value always being considerably more than the corresponding increase in oxygen uptake (Table 3) . It is possible that ascorbic acid catalyses the split of malonaldehyde or other component of the peroxidized fatty acids that reacts in the thiobarbituric acid method of determination and that the total increase in thiobarbituric acid value observed when ascorbic acid is added is not due to genuine peroxide formation.
The enhanced rate of lipid 'peroxide' formation observed when ascorbic acid is added to tissue homogenates may arise from the catalytic system formed from non-haem iron and ascorbic acid. Alternatively, ascorbate in the presence of a heavy metal such as iron could form hydrogen peroxide, a process that may initiate a rapid rate of peroxidation possibly through the intermediary formation of hydroxyl radicals. The iron content of each tissue, and whether the iron is in the haem form, clearly has an important effect on catalysis. Spleen has the greatest content of haem iron (Table 7) and, although the quantity of non-haem iron is high, this iron is probably mainly as ferritin and haemosiderin and therefore unavailable for catalysis. Catalysis by spleen homogenate is probably mainly a result of haemoprotein activity. In support ofthis Fig. 1 shows that high concentrations of spleen homogenate tend to inhibit peroxidation of fatty acids exactly as haemoproteins do (Lewis & Wills, 1963) , and catalysis by spleen homogenate is very little affected by ascorbic acid. On the other hand catalysis in kidney homogenates depends, to a large extent, on the relatively large quantity of non-haem iron, and catalysis by kidney homogenate is strongly stimulated by ascorbic acid (Table 3) . Although purified ferritin is ineffective as a catalyst, the iron can be released by ascorbic acid to become an effective catalyst. Whenever ferritin is present in the tissue ascorbic acid can therefore perform a dual role, first in releasing iron from the ferritin and secondly by forming an active catalytic system with the iron.
At pH 6*0 the rate of peroxidation of linoleic acid or linolenic acid increased with increasing homogenate concentration up to a specific concentration of homogenate. Further increases in concentration of homogenate did not increase the rate of peroxidation (Fig. 1) . This concentration effect is pH-dependent and concentrated homogenates are very effective catalysts in acid solutions but very weak catalysts on the alkaline side of neutrality (Figs. 2 and 3) . It has been shown (Wills, 1965) that catalysis of lipid peroxide formation by inorganic iron is pH-dependent, the optimum rate of peroxidation being close to pH 5 5, and catalytic activity is weak when the reaction mixture is more alkaline than pH 7O0. It is therefore likely that a major portion of the catalytic activity of homogenates in acid solutions is due to non-haem iron but as the reaction is made more alkaline the proportion of total catalysis due to haemoproteins increases. If the homogenate concentration is increased in an alkaline solution then the inhibiting effects of high concentrations of haemoproteins become apparent. Several other experiments demonstrate the complex roles of inorganic iron (non-haem) and haemoproteins in peroxide formation. EDTA powerfully inhibits iron-catalysed peroxidation of unsaturated fatty acids but has no effect on haemoprotein-catalysed oxidation (Wills, 1965) . EDTA partially inhibited peroxide formation in added linolenic acid catalysed by liver or kidney homogenates but had little effect on catalysis by heart or spleen homogenates (Table 5 ). In these latter tissues it is therefore likely that haemoproteins are of major importance in the catalysis, whereas non-haem iron is at least as important as haemoproteins in kidney or liver. Effects of chelating agents on endogenous 'peroxide' formation are often different from their effects on the peroxidation of added unsaturated fatty acids. For example, endogenous 'peroxide' formation in spleen and kidney is powerfully inhibited by EDTA but peroxidation of added linolenic acid was much less affected. From these experiments it may be inferred that endogenous 'peroxide' formation is catalysed mainly by non-haem iron, or other metal, contained in the tissues, whereas haemoproteins catalyse the peroxidation ofadded linolenic acid. The effect of o-phenanthroline is difficult to interpret. The rate of peroxidation of added fatty acids is strongly accelerated by the addition of o-phenanthroline, and this is presumably due to the formation of an iron-o-phenanthroline complex. The inhibition of endogenous 'peroxide' formation by o-phenanthroline is in direct contrast with its enhancing effect on the rate of peroxidation of added fatty acid emulsions. It has been shown (Wills, 1965) that o-phenanthroline inhibits cobaltcatalysed peroxidation in model systems and it is therefore powsible that a metal other than iron is partially or primarily responsible for 'peroxide' formation in incubated homogenates.
Thiol compounds, cysteine and GSH, accelerate catalysis of peroxide formation by inorganic iron (Wills, 1965) but delay haemoprotein-catalysed peroxidation (Lewis & Wills, 1963; Wills, 1965) .
GSH at a concentration of 1 mm inhibited the Vol. 99 675 peroxidation catalysed by homogenates but it became an activator at concentrations greater than 2mm. Catalysis by cytochrome c was, under similar conditions, inhibited by GSH at this high concentration. It therefore appears that low concentrations of GSH inhibit haemoprotein-catalysed peroxidation, whereas higher concentrations cause an increase in peroxidation catalysed by nonhaem iron. All fractions of liver studied possessed catalytic activity for the peroxidation of unsaturated fatty acids but little activity was associated with the nuclear fraction. The effects of chelating agents, ascorbic acid and thiol compounds indicated that in most fractions catalysis by haemoprotein and non-haem iron are both important. In the mitochondrial and microsomal fraction, haemoproteins are likely to be more important because ascorbic acid inhibited peroxidation of fatty acids and, further, decrease of the cytochrome c content of the mitochondria considerably diminished the catalytic activity. Ascorbic acid strongly stimulated catalysis by the 100 OOOg supematant and presumably non-haem iron is important in this fraction.
Most of the experiments described therefore implicate both non-haem iron and haemoproteins in the catalysis of lipid peroxide formation. Stored iron in the form of ferritin cannot catalyse lipid peroxide formation but iron released in an inorganic (non-haem) form or converted into haemoprotein is active catalytically. Ascorbic acid releases iron from ferritin. Inorganic iron either as Fe2+ or Fe3+ is a very weak catalyst unless activated by a reducing agent (Wills, 1965) : either ascorbic acid or thiol compounds can function in this role. Iron-catalysed oxidation is pH-sensitive and most active in acid conditions. Haemoprotein-catalysed oxidation on the other hand is little affected by pH and is inhibited, at least temporarily, by reducing agents such as ascorbic acid or thiol compounds.
Lipid peroxide formation in tissues will also depend on the tissue content of tocopherol and other antioxidants (Bieri & Anderson, 1960; Zalkin & Tappel, 1960) but no attempt has been made to vary the dietary and therefore the concentration of antioxidant in the tissues in the present investigation.
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